Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D. Shanafelt, Martin S. Tallman, Susan O’Brien et al.|New England Journal of Medicine|2019Cited by 735
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosisTania Jain, Jeanne Palmer, Katie L. Kunze et al.|Bone Marrow Transplantation|2018Cited by 46